Kaye Scholer Defends Viagra from Generic Challenge in Patent Fight with Teva
A Virginia federal judge has ruled that Pfizer’s patent for Viagra is valid until 2019, dealing a huge defeat to Teva Pharmaceuticals, which had gained tentative FDA approval to market a generic version of the drug and hoped to start selling it by next year.